Amplification and Overexpression of the MDM2 Gene in a Subset of Human Malignant Gliomas without p53 Mutations

Cancer Research

Volumn 53, Issue 12, 1993, Pages 2736-2739

  Liu, Lu ^b   Collins, V Peter ^a,b   Schmidt, Esther E ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT;

ALLELE; ARTICLE; CANCER CONTROL; CANCER GROWTH; CHROMOSOME 17; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ASTROCYTOMA; BASE SEQUENCE; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 17; GENE AMPLIFICATION; GENE REARRANGEMENT; GENES, P53; GLIOMA; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; PROTEIN P53; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0027196974     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Collins, V.P. Amplified genes in human gliomas. Semin. Cancer Biol. 4: 27-33, 1993.
2. Frankel. R. Bayonu, W. Koslow, M. and Newcombe, E.W. p. 3 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequence. Cancer Res. 52: 1427-1433. 1992.
3. Fults. D. Brockmeyer, D. Tallours, M.W. Pedone, C.A. and Cawthon, R. p. 3 mutation and loss of heterozygosity on chromosome 17 and 10 during astrocytoma progression. Cancer Res. 52: 674-679. 1992.
4. von Deimling, A. Eibl, R.H. Oghaki, H. Louis, D.N. von Ammon, K. Petersen, I. Kleihues, P. Chung, R.Y. Wiestler, O.D. and Seizinger, B.R. p. 3 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res. 52: 2987-2990. 1992.
5. Oghaki, H. Eibl, R.H. Wiestler, O.D. Yasargil, M.G. Newcomb, E.W. and Kleihues, P. p. 3 mutations in nonastrocytic brain tumors. Cancer Res. 51: 6202-6205. 1991.
6. Saylors, R.L. III, Sidransky, D. Friedman, H.S. Bigner, S.H. Bigner, D.D. Vogelstein, B. and Brodeur, G.M. Infrequent p. 3 gene mutations in medulloblasto-mas. Cancer Res. 51: 4721-4723. 1991.
7. Saxena, A. Clark, W.C. Robertson, J.T. Ikejiri, B. Oldfield, E.H. and Ali. I.U. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p. 3 in malignant atrocytomas. Cancer Res. 52: 6716-6721, 1992.
8. Levine, A.J. Momand, J. and Finlay, C.A. The p. 3 tumour suppressor gene. Nature, (Lond.), 351: 453-456, 1991.
9. Momand. J. Zambetti, G.P. Olson, D.C. George, D.L. and Levine, A.J. The mdm-2 oncogene product forms a complex with the p. 3 protein and inhibits p. 3-mediated trans-activation. Cell, 69: 1237-1245, 1992.
10. Cahilly-Snyder, L. Yang-Feng, T. Francke, U. and George, D.L. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somatic Cell. Mol. Genet. 13: 235-244, 1987.
11. Fakharzadeh, S.S. Trusko, S.P. and George, D.L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBOJ. 10: 1565-1569, 1991.
12. Finlay, C.A. The mdm-2 oncogene can overcome wild-type p. 3 suppression of transformed cell growth. Mol. Cell. Biol. 13: 301-306, 1993.
13. Oliner, J.D. Kinzler, K.W. Meltzer, P.S. George, D.L. and Vogelstein, B. Amplification of a gene encoding a /?5J-associated protein in human sarcomas. Nature (Lond.), 358: 80-83, 1992.
14. Kleihues, P. Burger, P.C. and Scheithauer, B. Histological typing of tumours of the central nervous system. Berlin: Springer-Verlag, in press, 1993.
15. Bergerheim, U. Nordenskjold, M. and Collins, V.P. Deletion mapping in human renal cell carcinoma. Cancer Res. 49: 1390-13%, 1989.
16. Ekstrand, A.J. James, C.D. Cavenee, W.K. Seliger, B. Pettersson, R.F. and Collins, V.P. Genes for epidermal growth factor receptor, transforming growth factor a, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 51: 2164-2172, 1991.
17. Reifenberger, G. Szymas, J. and Wechsler, W. Differential expression of glial and neuronal associated antigens in human tumors of the central and peripheral nervous system. Acta Neuropathol. (Berl.), 74: 105-123, 1987.
18. Hollstein, M.C. Sidransky, D. Vogelstein, B. and Harris, C.C. p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
19. Ladanyi, M. Cha, C. Lewis, R. Jhanwar, S.C. Huvos, A.G. and Healey, J.H. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 53: 16-18, 1993.
20. Heim, S. and Mitelman, F. Cytogenetics of solid tumors. Recent Adv. Histopathol. 15: 37-66, 1992.
21. Bigner, S.H. Mark, J. Burger, P.C. Mahaley, S. Bullard, D.E. Muhlbaier, L.H. and Bigner, D.D. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res. 48: 405-411, 1988.
22. Jenkins, R.B. Kimmel, D.W. Moertel, C.A. Schultz, C.G. Scheithauer, B.W. Kelly, P.J. and Dewald, G.W. A cytogenetic study of 53 human gliomas. Cancer Genet. Cytogenet. 39: 253-279, 1989.
23. Kallioniemi, A. Kallioniemi, O.P. Sudar, D. Rutovitz, D. Gray. J.W. Waldman. F. and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Washington DC), 258: 818-821, 1992.